Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?

Sonal Agarwala Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, USAView further author information

Andrew Kowalskia Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, USAView further author information

Molly Schiffera Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, USAView further author information

Jennifer Zhaoa Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, USAView further author information

Jan Philipp Bewersdorfb Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA

Amer M. Zeidanc Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, and Yale Cancer Center, New Haven, CT, USACorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window